Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mivacurium intubation timing study
ChiCTR1900026781Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mivacurium in None (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Proportion of patients with excellent intubation condition. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
mivacurium
Beyond the preview
Go deeper on ChiCTR1900026781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026781.